128 related articles for article (PubMed ID: 24954079)
1. Improvement of ischaemic macular oedema after intravitreal injection of autologous bone marrow-derived haematopoietic stem cells.
Siqueira RC; Messias A; Gurgel VP; Simões BP; Scott IU; Jorge R
Acta Ophthalmol; 2015 Mar; 93(2):e174-6. PubMed ID: 24954079
[No Abstract] [Full Text] [Related]
2. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
Sakuma T; Mizota A; Inoue J; Tanaka M
Am J Ophthalmol; 2010 Dec; 150(6):876-82. PubMed ID: 20801424
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
Udaondo P; Garcia-Delpech S; Salom D; Garcia-Pous M; Díaz-Llopis M
Am J Ophthalmol; 2011 Aug; 152(2):326-7; author reply 327-8. PubMed ID: 21784203
[No Abstract] [Full Text] [Related]
4. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
[TBL] [Abstract][Full Text] [Related]
5. Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Shimada K
Retina; 2012 Oct; 32(9):1844-52. PubMed ID: 22653545
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Er H
Am J Ophthalmol; 2006 Oct; 142(4):710; author reply 710. PubMed ID: 17011888
[No Abstract] [Full Text] [Related]
7. Region-specific ischemia, neovascularization and macular oedema in treatment-naïve proliferative diabetic retinopathy.
Lange J; Hadziahmetovic M; Zhang J; Li W
Clin Exp Ophthalmol; 2018 Sep; 46(7):757-766. PubMed ID: 29412501
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial.
Siqueira RC; Messias A; Voltarelli JC; Scott IU; Jorge R
Retina; 2011 Jun; 31(6):1207-14. PubMed ID: 21293313
[TBL] [Abstract][Full Text] [Related]
9. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
[TBL] [Abstract][Full Text] [Related]
10. Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.
Rensch F; Jonas JB; Spandau UH
Acta Ophthalmol; 2009 Feb; 87(1):77-81. PubMed ID: 18937800
[TBL] [Abstract][Full Text] [Related]
11. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
[TBL] [Abstract][Full Text] [Related]
12. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
[No Abstract] [Full Text] [Related]
13. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
14. Spectral domain optical coherence tomography predictors of visual outcome in diabetic cystoid macular edema after bevacizumab injection.
Al Faran A; Mousa A; Al Shamsi H; Al Gaeed A; Ghazi NG
Retina; 2014 Jun; 34(6):1208-15. PubMed ID: 24368308
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
17. [Intravitreal ranibizumab for diabetic macula edema].
Alpatov SA; Zlobin IV; Shchuko AG; Malyshev VV
Vestn Oftalmol; 2011; 127(5):34-8. PubMed ID: 22165097
[TBL] [Abstract][Full Text] [Related]
18. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
20. Focal macular electroretinogram in macular edema secondary to central retinal vein occlusion.
Ogino K; Tsujikawa A; Nakamura H; Miyamoto K; Murakami T; Muraoka Y; Kurashige Y; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3514-20. PubMed ID: 21398283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
